This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research, Universite Droit Et Sante Lille Ii. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 65 
1 out of 1,853 
1 out of 2 Years Active: 2016
Title: The Innovative Contributions of Hana Kammoun
Introduction
Hana Kammoun is a notable inventor based in La Madeleine, France. She has made significant strides in the field of biotechnology, particularly in the development of vaccines. Her work focuses on creating genetically attenuated strains that can be utilized for the treatment and prevention of infectious diseases.
Latest Patents
Hana Kammoun holds 1 patent for her innovative work. The patent describes a genetically attenuated strain that includes a mutated pertussis toxin (ptx) gene and a heterologous ampG gene. Additionally, it features a hybrid protein that combines the N-terminal fragment of filamentous haemagglutinin (FHA) with a heterologous epitope or antigenic protein. This strain has potential applications in attenuated vaccines aimed at combating infectious diseases.
Career Highlights
Throughout her career, Hana Kammoun has been associated with prestigious institutions such as Université Droit et Santé Lille II and Institut National de la Santé et de la Recherche Médicale. Her contributions to the field of medical research have been recognized and valued by her peers.
Collaborations
Hana has collaborated with esteemed colleagues, including Camille Locht and Nathalie Mielcarek, who have also made significant contributions to the field of medical research.
Conclusion
Hana Kammoun's innovative work in vaccine development showcases her dedication to advancing medical science. Her patented inventions have the potential to make a lasting impact on public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile